Published in Transplant Weekly, May 11th, 1998
Residual recipient lymphoid cells may have produced multiple red cell (RBC) alloantibodies in the early posttransplant period.
"This is the first reported case of severe immune hemolytic anemia due to multiple RBC alloantibodies after an allogeneic bone marrow transplant," wrote Aurelio Lopez and colleagues from La Fe University Hospital, Valencia, Spain ("Severe Hemolytic Anemia Due to Multiple Red Cell Alloantibodies after an ABO-Incompatible Allogeneic Bone Marrow Transplant," Transfusion, 1998;38:247-251).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Transplant Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.